Zymo Research Reaffirms Commitment to American Manufacturing

I’m reaching out from Zymo Research to share our latest press release highlighting our commitment to American manufacturing. With the majority of our products—including key components and materials—designed, manufactured, and assembled in Southern California, we are dedicated to delivering high-quality, reliable solutions to researchers worldwide. Given your focus on [Relevant Industry/Fields], we believe this announcement will be of great interest to your audience. Our USA-based operations not only ensure stringent quality control and supply chain stability but also allow us to maintain consistent pricing, even amidst evolving trade conditions.

Qureight and Remedy Cell partner to integrate deep learning platform into Phase 1b study of RC-0315 in IPF

Qureight Ltd. and Remedy Cell are integrating the latest AI deep learning technology into a Phase 1b study of RC-0315, to develop a novel therapy for the fatal lung condition Idiopathic Pulmonary Fibrosis (IPF).

Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD

Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD

Syngene Acquires its First Manufacturing Facility in the US

Genome Canada and Oxford Nanopore Technologies team up to advance genomics research in Canada

Genome Canada and Oxford Nanopore Technologies announced a collaboration aimed at significantly enhancing genomics research across Canada.

Announcing BixBench: A Benchmark to Evaluate AI Agents on Bioinformatics Tasks

Today, in partnership with ScienceMachine, FutureHouse is introducing BixBench, a benchmark designed to evaluate AI agents on real-world bioinformatics tasks. BixBench challenges AI models with open-ended analytical research scenarios, requiring them to analyze data, generate insights, and interpret results autonomously.

Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials

Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence and clinical research organization, today announce a partnership to utilize the participant management and payments platform, Mural Link.

Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas

Owkin, a pioneer in Agentic AI for decoding the complexities of biology, has launched a comprehensive multimodal patient data discovery program to accelerate multimodal data access and advance medical research.

Biocair Announces Further Expansion in the APAC Region As Part of Global Growth Strategy

Biocair, an established global leader in life science logistics, announces the expansion of its operations with the opening of a new office in Chengdu, Sichuan Province, China.

eClinical Solutions Details Strong 2024 and Announces New Products Aimed at Reducing Cycle Times for Biopharma

Company prioritizes efficiency through innovation with new embedded AI and automation platform capabilities, including a GenAI-Powered Chatbot and Clean Progress Tracking

Oxford Nanopore expands compatibility with 10x Genomics to unlock deeper insights in single-cell transcriptomics

Oxford Nanopore has expanded its collaboration with 10x Genomics to help improve single-cell transcriptomics research.

Vector Laboratories Announces the Appointment of Ashley Scholz as Vice President of Marketing

Vector Laboratories has appointed Ashley Scholz as its new Vice President of Marketing. Ashley brings 16+ years of experience in medical devices, cancer diagnostics, and molecular diagnostics, most recently leading marketing at W.L. Gore & Associates.

Sphere Fluidics rebrands to Sphere Bio

Sphere Fluidics today announced its rebranding to Sphere Bio. The name change marks a significant milestone in the Company’s development, reflecting its transition from a leading droplet-based microfluidics innovator to an established commercial provider of integrated life sciences tools and solutions.

Qureight core imaging platform deployed within Vicore Phase 2b ASPIRE study of buloxibutid for IPF

Qureight Ltd and Vicore Pharma today announce the implementation of Qureight’s Core Imaging Platform within the global Phase 2b ASPIRE trial investigating buloxibutid in patients with idiopathic pulmonary fibrosis (IPF).

VECTOR LABORATORIES ANNOUNCES PARTNERSHIP WITH BRITISH BIOTECH INNOVATOR ETCEMBLY

Vector Laboratories and Etcembly announce a collaboration to accelerate recombinant antibody therapeutic development. The collaboration combines Vector’s antibody expertise with AI-driven insights from Etcembly’s award-nominated platform.

Velsera Drives Momentum in 2024 with Key Platform Advancements and Strategic Growth

ClearNote Health Earns Approval for Avantect® Pancreatic Cancer Test from New York State Department of Health

ClearNote Health announced New York State has approved its Avantect Pancreatic Cancer Test. The ClearNote Health Laboratory now has its NYSDOH permit, as well as its CLIA certification and CAP accreditation.

ResultsCX Rises to ‘Innovator’ Status in Avasant’s CX Center Business Process Transformation RadarView™ Assessment

Cleveland Clinic Announces the Rollout of Ambience Healthcare’s AI Platform

CluePoints named as Finalist in 2025 ACDM Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has been shortlisted for “Team Excellence in the Management of Clinical Data” at the 2025 ACDM Awards.